BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 12806695)

  • 21. A review of risk measures in pharmacoepidemiology with tips for statisticians in the pharmaceutical industry.
    Quartey G; Wang J; Kim J
    Pharm Stat; 2011; 10(6):548-53. PubMed ID: 22127819
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A beneficial side effect of the Medicare drug benefit.
    Platt R; Ommaya A
    N Engl J Med; 2005 Dec; 353(26):2742-3. PubMed ID: 16382059
    [No Abstract]   [Full Text] [Related]  

  • 23. [Social inequalities in health. Analysis using data from statutory health insurance companies].
    Geyer S
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2008 Oct; 51(10):1164-72. PubMed ID: 18985410
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Databases for pediatric medicine research in Europe--assessment and critical appraisal.
    Neubert A; Sturkenboom MC; Murray ML; Verhamme KM; Nicolosi A; Giaquinto C; Ceci A; Wong IC;
    Pharmacoepidemiol Drug Saf; 2008 Dec; 17(12):1155-67. PubMed ID: 18979461
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Research on drug safety and effectiveness using pharmacoepidemiological databases.
    Andersen M
    J Intern Med; 2014 Jun; 275(6):548-50. PubMed ID: 24635741
    [No Abstract]   [Full Text] [Related]  

  • 26. [Using claims data for small area analysis and controlling of hospital care].
    Swart E; Deh U; Robra BP
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2008 Oct; 51(10):1183-92. PubMed ID: 18985412
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Common Models, Different Approaches.
    Gagne JJ
    Drug Saf; 2015 Aug; 38(8):683-6. PubMed ID: 26088718
    [No Abstract]   [Full Text] [Related]  

  • 28. Propensity score methods in drug safety studies: practice, strengths and limitations.
    Wang J; Donnan PT
    Pharmacoepidemiol Drug Saf; 2001; 10(4):341-4. PubMed ID: 11760497
    [No Abstract]   [Full Text] [Related]  

  • 29. Drug utilization studies within the VIDEOFAR project.
    Maggini M; Menniti Ippolito F; Spila Alegiani S; Traversa G; Fortini M
    Ann Ist Super Sanita; 1991; 27(2):201-6. PubMed ID: 1755571
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The data page. Consumer confusion: are EMRs worth the risk?
    Runy LA
    Hosp Health Netw; 2005 Apr; 79(4):34. PubMed ID: 15916342
    [No Abstract]   [Full Text] [Related]  

  • 31. [Secondary data analysis in the field of epidemiology of health care. Potential and limitations].
    Hoffmann W; Bobrowski C; Fendrich K
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2008 Oct; 51(10):1193-201. PubMed ID: 18985413
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Validity of perinatal pharmacoepidemiologic studies using data from the RAMQ administrative database.
    BĂ©rard A; Lacasse A
    Can J Clin Pharmacol; 2009; 16(2):e360-9. PubMed ID: 19553702
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Using 'big data' to validate claims made in the pharmaceutical approval process.
    Wasser T; Haynes K; Barron J; Cziraky M
    J Med Econ; 2015; 18(12):1013-9. PubMed ID: 26548546
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacovigilance in pregnancy using population-based linked datasets.
    Colvin L; Slack-Smith L; Stanley FJ; Bower C
    Pharmacoepidemiol Drug Saf; 2009 Mar; 18(3):211-25. PubMed ID: 19173342
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Measurement of medical outcome quality using administative data in Germany].
    Heller G
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2008 Oct; 51(10):1173-82. PubMed ID: 18985411
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of data extraction from standardized versus traditional narrative operative reports for database related research and quality control.
    McLeod RS
    Surgery; 2007 Sep; 142(3):420-1. PubMed ID: 17723897
    [No Abstract]   [Full Text] [Related]  

  • 37. [Visits to the home for the aged and new EBM. Now we must correct the numbers for weeks!].
    Bauer M; Schober HJ
    MMW Fortschr Med; 2005 Sep; 147(39):18. PubMed ID: 16245774
    [No Abstract]   [Full Text] [Related]  

  • 38. [The National Health Insurance database of Hungary from the viewpoint of a health insurance physician].
    Gresz M
    Orv Hetil; 2012 Aug; 153(31):1234-9. PubMed ID: 22846492
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Use of administrative medical databases in population-based research.
    Gavrielov-Yusim N; Friger M
    J Epidemiol Community Health; 2014 Mar; 68(3):283-7. PubMed ID: 24248997
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Combining electronic healthcare databases in Europe to allow for large-scale drug safety monitoring: the EU-ADR Project.
    Coloma PM; Schuemie MJ; Trifirò G; Gini R; Herings R; Hippisley-Cox J; Mazzaglia G; Giaquinto C; Corrao G; Pedersen L; van der Lei J; Sturkenboom M;
    Pharmacoepidemiol Drug Saf; 2011 Jan; 20(1):1-11. PubMed ID: 21182150
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.